Team Health Holdings (TMH) was initiated at UBS with a buy rating. Major beneficiary of health care reform with steady core growth, UBS said. Twelve-month price target is $54.
(WAIR) was upgraded at RBC Capital to outperform from sector perform. Twelve-month price target is $27. Company can grow organically and through acquisitions, RBC Capital said.
Stock Comments / EPS Changes
Access Midstream Partners (ACMP) price target, EPS estimates were increased at Jefferies. Shadow backlog and acquisitions could drive incremental cash flow. Twelve-month price target is now $64. Buy rating.
Alexion Pharmaceuticals (ALXN) price target, EPS estimates were increased at UBS. Well-positioned with faster ramp of sales in France and opportunity to lever the operating model, UBS said. Twelve-month price target is now $202. Buy rating.
DDR (DDR) price target was raised at UBS. Sale of Brazil investment removes overhang associated with region's macro issues and supply concerns in the retail real estate market, UBS said. Twelve-month price target is $21. Buy rating.Kroger (KR) price target, EPS estimates were lifted at UBS. Operating profit upside is coming from fuel, not food. Twelve-month price target is now $43. Neutral rating. United Natural Foods (UNFI) price target was increased at UBS. Twelve-month price target is now $75. Continued acceleration in independent channel growth, UBS said. Neutral rating. Urban Outfitters (URBN) numbers were reduced at Nomura. Twelve-month price target is now $39. Estimates also reduced, given challenges at the core retail store, Nomura said. Neutral rating.
Follow TheStreet on Twitter and become a fan on Facebook